About the MenB mandate
ALL Oregon State University Corvallis students age 25 and under must be vaccinated against Meningococcal B disease (MenB).
By Feb. 15, you must have received two doses of Bexsero® or two out of three needed doses of Trumenba® (third dose of Trumenba® to be administered 6 months following the first dose).
Written documentation (pharmacy receipt, vaccine record from healthcare provider, etc.) must be provided. Student name and ID number must be included with documentation so the information is recorded correctly.
Written documentation can be submitted the following ways:
- Drop boxes in the Plageman Building 1st and 2nd floors
- U.S. Post to Immunization Office, 201 Plageman Building, Oregon State University, Corvallis OR 97331
Failure to comply with this requirement will result in an academic hold. You will not be able to get winter term final grades and you will not be able to register for spring term classes. Do not wait to get your vaccine. Begin as soon as possible. Doses must be given at least 28 days apart.
Most pharmacies and healthcare providers can provide MenB vaccinations. Call ahead to check on vaccine availability. The provider may need a day or two to order the vaccine for you.
If you already have begun your vaccination series, continue with the same brand of vaccine. You can visit Student Health Services, the SHS Pharmacy, or community pharmacies and healthcare providers to receive remaining doses.
The Oregon Legislature now requires Oregon private insurance plans to cover MenB vaccinations. Contact your insurance provider to check your coverage.
If you have any problems obtaining coverage through your Oregon insurer, contact the state of Oregon's Office of Patient Advocates at 1-888-877-4894 or send them an email.
This site will be updated as new information is available.
- Measles, Mumps, and Rubella (MMR)– 2 doses
- Varicella (Chickenpox)– 2 doses or the date of disease
- Hepatitis B - 3 doses
- Tetanus Diphtheria Pertussis (Tdap)– 1 dose received during or after 2005
- Meningococcal (MCV4)– 1 dose for all students under age 22. This must be received on or after turning age 16.
- Meningococcal B– 2 doses of Bexsero® or 3 doses of Trumenba® for all students age 25 and under.